{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:29:49Z","timestamp":1790094589153,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17GRNT33670993"],"award-info":[{"award-number":["17GRNT33670993"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.hrthm.2019.12.009","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T20:16:25Z","timestamp":1576181785000},"page":"358-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Sudden cardiac death risk prediction in heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-8596","authenticated-orcid":false,"given":"Sel\u00e7uk","family":"Adabag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Langsetmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2019.12.009_bib1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.12.009_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.hfc.2014.04.003","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"10","author":"Andersson","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hrthm.2019.12.009_bib3","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.12.009_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.12.009_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hrthm.2019.12.009_bib6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of death in heart failure with preserved ejection fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.12.009_bib7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/eurjhf\/hft062","article-title":"How do patients with heart failure with preserved ejection fraction die?","volume":"15","author":"Chan","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.12.009_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.12.009_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cardfail.2012.08.357","article-title":"Sudden cardiac death in heart failure patients with preserved ejection fraction","volume":"18","author":"Adabag","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2019.12.009_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10741-016-9525-z","article-title":"Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?","volume":"21","author":"Vaduganathan","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hrthm.2019.12.009_bib11","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1001\/jama.2008.553","article-title":"Sudden death after myocardial infarction","volume":"300","author":"Adabag","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.12.009_bib12","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.12.009_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ejhf.172","article-title":"A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction","volume":"16","author":"Adabag","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.12.009_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.12.009_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2017.1413","article-title":"Association of implantable cardioverter defibrillators with survival in patients with and without improved ejection fraction: secondary analysis of the Sudden Cardiac Death in Heart Failure Trial","volume":"2","author":"Adabag","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2019.12.009_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.12.009_bib17","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.12.009_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacep.2017.02.006","article-title":"Efficacy of implantable cardioverter-defibrillator therapy in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Anantha Narayanan","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.12.009_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jchf.2018.02.014","article-title":"Sudden death in heart failure with preserved ejection fraction: a competing risks analysis from the TOPCAT Trial","volume":"6","author":"Vaduganathan","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2019.12.009_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.resuscitation.2016.10.029","article-title":"Outcomes of sudden cardiac arrest in a state-wide integrated resuscitation program: results from the Minnesota Resuscitation Consortium","volume":"110","author":"Adabag","year":"2017","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.hrthm.2019.12.009_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002670","article-title":"Early access to the cardiac catheterization laboratory for patients resuscitated from cardiac arrest due to a shockable rhythm: the Minnesota Resuscitation Consortium Twin Cities Unified Protocol","volume":"5","author":"Garcia","year":"2016","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.hrthm.2019.12.009_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1536867X0400400201","article-title":"Cumulative incidence estimation in the presence of competing risks","volume":"4","author":"Coviello","year":"2004","journal-title":"Stata J"},{"key":"10.1016\/j.hrthm.2019.12.009_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.hrthm.2019.12.009_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.athoracsur.2012.04.089","article-title":"Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations","volume":"94","author":"Garcia","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hrthm.2019.12.009_bib25","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.hrthm.2014.06.038","article-title":"Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter","volume":"11","author":"Voight","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.12.009_bib26","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.12.009_bib27","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jacc.2017.03.568","article-title":"Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators","volume":"69","author":"Bilchick","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.12.009_bib28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.12.009_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.12.009_bib30","first-page":"A11898","article-title":"Heart failure with preserved ejection fraction is a highly arrhythmogenic disease [abstract]","volume":"140","author":"Gutierrez","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.12.009_bib31","first-page":"A11658","article-title":"Ventricular tachycardia is a common arrhythmia among patients with heart failure with preserved ejection fraction [abstract]","volume":"140","author":"Ash","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.12.009_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119311014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119311014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:49:49Z","timestamp":1761547789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527119311014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1547527119311014"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.12.009","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sudden cardiac death risk prediction in heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}